50% of adults living with diabetes remain undiagnosed. Given the significant population health implications of missed or delayed detection, an immediate step-change is required in how we test for diabetes. Digostics offers the world's first and only alternative to in-clinic oral glucose tolerance testing (OGTT) by enabling this crucial diabetes test to be performed at home. Simplified testing. Increased patient throughput. Better outcomes.
| Website | https://www.digostics.com |
| Revenue | $1 million |
| Employees | 17 (7 on RocketReach) |
| Industry | Medical and Diagnostic Laboratories, Manufacturing General, Manufacturing |
| Keywords | Diabetes Testing, Diagnostic Tests, Blood Glucose Monitoring, Diabetes Care, Medical Diagnostics, Diabetes Management, Health Diagnostics, Disease Detection, Point Of Care Testing, Diagnostic Tools, Clinical Diagnostics, Preventative Healthcare, Home Diagnostics, At Home Testing, Medical Devices, Health Technology, Digital Health |
| Competitors | Siemens, Roche, Thermo Fisher Scientific, Abbott, BD, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325413 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Digostics employee's phone or email?
The Digostics annual revenue was $1 million in 2026.
James Jackson is the Founder and CEO of Digostics.
7 people are employed at Digostics.
The NAICS codes for Digostics are [325413, 32541, 32, 3254, 325].
The SIC codes for Digostics are [283, 28].